BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
24 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
02 avr. 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
01 avr. 2024 16h05 HE
|
Biostem Technologies
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
21 mars 2024 08h00 HE
|
Biostem Technologies
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
26 févr. 2024 10h39 HE
|
PRISM MarketView
PRISM MarketView Highlights BioStem Technologies as it Targets Significant Opportunity in Wound Care Markets
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
30 janv. 2024 16h05 HE
|
Biostem Technologies
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
11 janv. 2024 08h30 HE
|
Biostem Technologies
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer role
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
19 déc. 2023 08h30 HE
|
Biostem Technologies
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
14 déc. 2023 08h30 HE
|
Biostem Technologies
The Center for Medicare Services (CMS) has established national pricing for AmnioWrap2(TM) in all Medicare Administrative Contractors (MAC) regions
BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
23 mars 2023 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is...